Latest results

As a listed entity, we have a responsibility to communicate our strategy and performance to investors in order to promote confidence. Information for investors includes share information, share analysis, shareholder news and annual reports.

We’re confident in our future

Our bold ambitions for patients are reflected in new commitments to growth and a significant step-change in delivery over the next five years.

Erum Shakir Rahim CEO - GSK Pakistan

Reflections on 2022 performance

GSK Full Colour Icon


Pakistan Stock Exchange Symbol 


For complaints or queries please contact:

Mr. Agha Salman Taimur

Company Secretary

Phone No: +9221 111 475 725​, +922132316331​

Security And Exchange Commission Of Pakistan

DISCLAIMER: “In case your complaint has not been properly redressed by us, you may lodge your complaint with Securities and Exchange Commission of Pakistan (the “SECP”). However, please note that SECP will entertain only those complaints which were at first directly requested to be redressed by the Company and the company has failed to redress the same. Further, the complaints that are not relevant to SECP’s regulatory domain/competence shall not be entertained.”

Financial highlights

Key operation and financial data